Search only accepts letters and numbers.
Home
|
Advertising
|
Membership
|
Newsletters
|
Contact Us
|
About
|
BPC News
|
Submit Releases
|
Log Out
PREVIOUS ISSUES
NEWS BY INDUSTRY
All Latest News
Banking & Finance
BPC News Releases
Business Community Events
Business Record E-newsletters
Business Record Insider
Culture
Economic Development
Energy & Environment
Health & Wellness
HR & Education
Insurance & Investments
Iowa News
Law & Government
Lift IOWA
Manufacturing & Logistics
On The Move
On the Record
Opinion
Real Estate & Development
Retail & Business
Sales & Marketing
Tech & Innovation
The Insider Notebook
Transportation
SPECIALTY PRODUCTS
Annual Real Estate Magazine
Best of Des Moines
Book of Lists
BPC Book Publishing
Business Insights
Business Spotlight: Digital Video Profiles
Custom Publishing
Development Guides
Greater
innovationIOWA
Lift IOWA Newsletter
Made in Iowa
Newcomer's Guide
Pillars of Philanthropy
Special Advertising Sections
Made in Iowa
EVENTS
Buy Tickets
Upcoming Business Record Events
Trivia Night - Forty Under 40 20th anniv.
20th Anniversary Women of Influence
Book of Lists Unveiling Party
Economic Forecast
Commercial Real Estate Forum
Forty Under 40
innovationIOWA unveiling
Women of Influence
90 ideas in 90 minutes
Power Breakfast
AWARDS
CFO of the Year
Forty Under 40
Forty Under 40 Alumnus
CRE Pro of the Year
InnovationIOWA Awards
Women of Influence
CALENDAR
EXECUTIVE TOOLS
Public Notices
Reprints of Business Record
Request Rate Card
RSS Feeds
Video
Iowa researchers create safer, ethical stem cells
Thursday, June 29, 2017 3:31 PM
Iowa-based research firms Cellular Engineering Technologies and John Paul II Medical Research Institute announced they were successful in designing a way to create stem cells that are safer to transplant without causing tumors. Previously, induced pluripotent stem cells (IPSCs), which are adult cells converted back into a stem cell form, required two cancer-causing genes in order to complete the conversion. Researchers were able to replace these genes with alternative methods of converting the cells, reducing the risk of transplanted cells growing into tumors. IPSCs had already been viewed as a breakthrough by avoiding the use of embryonically derived cells and instead transforming skin or blood cells into the multiuse stem cell form.
X
Most Viewed
Most Commented
New skywalk proposed over Seventh Street in downtown Des Moines
Iconic 85-year-old mansion remains on the market
Good times go bad
Project update: The Fifth in downtown Des Moines
Ramping up behavioral health care in Central Iowa
Home
|
Advertising
|
Membership
|
Newsletters
|
Contact Us
|
About
|
BPC News
|
Submit Releases
|
Log Out
Facebook
Twitter
RSS
The Depot at 4th, 100 4th Street, Des Moines, Iowa 50309
|
(515) 288-3336
|
© 2019 Business Record. All Rights Reserved. |
Legal disclaimer
|
Privacy Policy
Software © 2019
1up! Software,
All Rights Reserved
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##